Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals Reports First Quarter 2009 Financial Results
Published in Health Business Week, May 22nd, 2009
“We currently have three novel agonists targeted to Toll-like Receptors in clinical development for different indications, two of which are being advanced and funded by our collaborators,” said Sudhir Agrawal, D.Phil., President, Chief Executive Officer and Chief Scientific Officer. “Additionally, we intend to submit an Investigational New Drug application by the end of 2009 for a fourth drug candidate, IMO-3100, which is a novel TLR antagonist for potential application in autoimmune diseases.”
“We ended the first quarter with $50.3...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-05-22)
More Articles from Health Business Week
- 1-800-FLOWERS.COM, Inc.
Send Mom Sweet Gifts from Cheryl&Co. - 104 West Partners
104 West Partners Awarded Three Hermes Creative Awards for Outstanding Public Relations Campaigns - 3M
3M Infection Prevention Division Launches New Sales Organization Representation for U.S. Physician Market - 3SBio Inc.
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor - A Schmahl Science Workshop
A Schmahl Science Workshop Brings Free H1N1 Swine Flu-Prevention Workshops and Volunteer Training to Silicon Valley Schools - A.M. Best Co.
A.M. Best Special Report: U.S. Health—2008 GAAP Financial Review - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
